UK markets close in 3 hours 42 minutes

Swedish Orphan Biovitrum AB (publ) (SOBI.ST)

Stockholm - Stockholm Real-time price. Currency in SEK
Add to watchlist
176.20+4.70 (+2.74%)
As of 01:48PM CET. Market open.
Full screen
Previous close171.50
Open171.50
Bid176.30 x 0
Ask176.30 x 0
Day's range171.30 - 176.50
52-week range127.10 - 245.40
Volume299,362
Avg. volume775,960
Market cap52.005B
Beta (5Y monthly)0.58
PE ratio (TTM)17.82
EPS (TTM)9.89
Earnings date10 Feb 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est192.13
  • Bloomberg

    Astra Sinks Advent’s $7.6 Billion Buyout of Biotech Sobi

    (Bloomberg) -- AstraZeneca Plc effectively blocked a $7.6 billion takeover of Swedish Orphan Biovitrum AB by withholding its 8% stake in the drugmaker from a buyout offer by Advent International and Singapore wealth fund GIC, according to people familiar with the situation.Most Read from BloombergThe Hot New Trend For Hedge Funds Is—Finally—Female Founders‘Ghost Signs’ Haunt London’s Reviving NeighborhoodsReliving the New York Subway Map DebateAutomating the War on Noise PollutionChina Cash Flow

  • Zacks

    Apellis' (APLS) Q3 Loss Widens, Revenues Surpass Estimates

    Apellis (APLS) reports wider-than-expected loss for the third quarter of 2021 while revenues surpass expectations.

  • Zacks

    Earnings Preview: Swedish Orphan Biovitrum (BIOVF) Q3 Earnings Expected to Decline

    Swedish Orphan Biovitrum (BIOVF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.